ATE426167T1 - Auto-antikírper gegen annexin-proteine als marker fur lungenkrebs - Google Patents

Auto-antikírper gegen annexin-proteine als marker fur lungenkrebs

Info

Publication number
ATE426167T1
ATE426167T1 AT06075982T AT06075982T ATE426167T1 AT E426167 T1 ATE426167 T1 AT E426167T1 AT 06075982 T AT06075982 T AT 06075982T AT 06075982 T AT06075982 T AT 06075982T AT E426167 T1 ATE426167 T1 AT E426167T1
Authority
AT
Austria
Prior art keywords
marker
lung cancer
antibodies against
annexin proteins
auto antibodies
Prior art date
Application number
AT06075982T
Other languages
English (en)
Inventor
Samir M Hanash
David Misek
Robert Hinderer
David Beer
Franck Brichory
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE426167T1 publication Critical patent/ATE426167T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4718—Lipocortins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT06075982T 1999-08-06 2000-08-04 Auto-antikírper gegen annexin-proteine als marker fur lungenkrebs ATE426167T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/370,337 US6645465B2 (en) 1999-08-06 1999-08-06 Annexin proteins and autoantibodies as serum markers for cancer

Publications (1)

Publication Number Publication Date
ATE426167T1 true ATE426167T1 (de) 2009-04-15

Family

ID=23459219

Family Applications (3)

Application Number Title Priority Date Filing Date
AT06075982T ATE426167T1 (de) 1999-08-06 2000-08-04 Auto-antikírper gegen annexin-proteine als marker fur lungenkrebs
AT00952594T ATE326699T1 (de) 1999-08-06 2000-08-04 Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs
AT09151524T ATE529751T1 (de) 1999-08-06 2000-08-04 Annexine als marker für lungenkrebs

Family Applications After (2)

Application Number Title Priority Date Filing Date
AT00952594T ATE326699T1 (de) 1999-08-06 2000-08-04 Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs
AT09151524T ATE529751T1 (de) 1999-08-06 2000-08-04 Annexine als marker für lungenkrebs

Country Status (10)

Country Link
US (5) US6645465B2 (de)
EP (3) EP1734368B1 (de)
JP (1) JP4594575B2 (de)
AT (3) ATE426167T1 (de)
AU (1) AU780772B2 (de)
CA (1) CA2380398C (de)
DE (2) DE60041839D1 (de)
DK (2) DK1734368T3 (de)
ES (2) ES2320585T3 (de)
WO (1) WO2001011372A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810040D0 (en) * 1998-05-11 1998-07-08 Univ Nottingham Blood borne tumour markers
GB9827228D0 (en) * 1998-12-10 1999-02-03 Univ Nottingham Cancer detection method and reagents
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US20030232399A1 (en) * 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
CA2385371A1 (en) * 2000-07-21 2002-01-31 Hiroshi Mizokami Method of purifying calcium ion-binding protein
US6962903B2 (en) 2001-02-21 2005-11-08 Alavita, Inc. Modified annexin proteins and methods for preventing thrombosis
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7214498B2 (en) * 2001-03-23 2007-05-08 Benaroya Research Institute At Virginia Mason Tumor associated antigens and methods of using the same
US20050037437A1 (en) * 2001-09-14 2005-02-17 Reinhard Zeidler Identification of antigen by xenogenic, allogenic or autologous antibody-mediated precipitation
EP1451587A4 (de) * 2001-11-09 2006-12-06 Benaroya Res Inst At Virginia Antigentafeln und verfahren zu deren verwendung
GB2424070B (en) * 2002-11-14 2007-06-27 Univ Nottingham Methods for preparing tumour marker proteins
EP1601969A2 (de) 2003-03-08 2005-12-07 Auvation Ltd Marker für dickdarmkrebs
PL1720611T3 (pl) * 2004-02-16 2010-09-30 Proteosys Ag Marker diagnostyczny dla raka
WO2005114192A1 (en) * 2004-05-13 2005-12-01 Centre National De La Recherche Scientifique A device for binding a target entity to a bait entity and detection methods using the same
AU2005280528B2 (en) 2004-07-30 2010-12-23 Adeza Biomedical Corporation Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
RU2277242C2 (ru) * 2004-08-23 2006-05-27 Александр Владимирович Балюра Способ диагностики опухолей
WO2006098144A1 (ja) * 2005-03-17 2006-09-21 National University Corporation Chiba University 特発性肺線維症の検出マーカー、検出キット及び検出方法
EP1724586A3 (de) * 2005-05-21 2007-07-04 ProteoSys AG Annexin für Krebsrisikomanagement
EP1724585A1 (de) * 2005-05-21 2006-11-22 ProteoSys AG Annexin für Krebsrisikofeststellung
GB2426581A (en) * 2005-05-27 2006-11-29 Univ Nottingham Immunoassay methods
BRPI0610267B8 (pt) 2005-05-27 2021-07-27 Oncimmune Ltd métodos de detecção de um estado doentio ou de uma suscetibilidade à doença em um indivíduo mamífero, e, uso do método
WO2006130525A2 (en) * 2005-05-31 2006-12-07 Sidney Kimmel Cancer Center Methods for immunotherapy of cancer
ATE462977T1 (de) * 2005-09-26 2010-04-15 Ulrich Loos Verfahren zum nachweis von autoimmunantikörpern gegen den tsh-rezeptor und neue tsh- rezeptorchimären
AU2006332597A1 (en) * 2005-11-10 2007-07-12 University Of Kentucky Research Foundation Lung cancer diagnostic assay
US9347945B2 (en) * 2005-12-22 2016-05-24 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
JP2010507069A (ja) * 2006-07-08 2010-03-04 ユニバーシティー オブ ケンタッキー リサーチ ファンデーション 肺癌診断アッセイ
CN101632020B (zh) 2006-09-13 2013-11-27 昂西免疫有限公司 改进的免疫测定方法
MX2009004460A (es) * 2006-10-26 2009-07-09 Abbott Lab Inmunoensayo de analitos en muestras que contienen anticuerpos anti-analito endogenos.
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
US7776605B2 (en) 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20090047689A1 (en) * 2007-06-20 2009-02-19 John Kolman Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
GB0725239D0 (en) * 2007-12-24 2008-02-06 Oncimmune Ltd Calibrator for autoantibody assay
CN102171569A (zh) * 2008-05-09 2011-08-31 杜克大学 检测和治疗癌症的自身抗体
US9581599B2 (en) 2010-06-28 2017-02-28 The Board Of Regents Of The University Of Texas System Diagnosis of benign and cancerous growths by measuring circulating tumor stem cells and serum AnnexinA2
WO2012048190A1 (en) * 2010-10-08 2012-04-12 Regents Of The University Of Minnesota Annexin ii compositions and methods
KR20150010882A (ko) * 2013-07-19 2015-01-29 삼성전자주식회사 아넥신 Ａ2 결합단백질, ｐ53 단백질 및 ｐ18 단백질을 포함하는 융합 단백질 및 이를 포함하는 암의 예방 또는 치료용 조성물
WO2015039175A1 (en) 2013-09-18 2015-03-26 Adelaide Research & Innovation Pty Ltd Autoantibody biomarkers of ovarian cancer
HUE060293T2 (hu) 2013-11-13 2023-02-28 Univ Minnesota Annexin II variáns készítmények és eljárások
CN104407151B (zh) * 2014-11-19 2016-06-08 汕头大学医学院 Kindlin-2，Myosin-9和Annexin II三蛋白联合预测食管鳞癌患者预后试剂盒
CN113721021B (zh) * 2021-09-16 2023-07-07 郑州大学 Prkcz自身抗体在食管鳞癌辅助诊断中的应用
CN116539885B (zh) * 2023-07-06 2023-09-29 上海秤信生物科技有限公司 用于乳腺癌早期检测的肿瘤自身抗原/抗体组合及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02496A (ja) * 1987-12-24 1990-01-05 Nippon Shinyaku Co Ltd モノクローナル抗体、製法、及び利用法
DE4012341A1 (de) * 1990-04-18 1991-10-24 Behringwerke Ag Monoklonale antikoerper gegen pp4, verfahren zu ihrer herstellung und ihre verwendung
DE4040306A1 (de) 1990-12-17 1992-06-25 Behringwerke Ag Verfahren zur bestimmung von antikoerpern gegen lipocortine
US5405749A (en) * 1991-12-06 1995-04-11 Polans; Arthur S. Method for identifying and purifying a cancer associated retinopathy autoantigen, and testing patient serum for the autoantibody to the autoantigen
JPH0772149A (ja) * 1993-06-30 1995-03-17 Nippon Shinyaku Co Ltd 肝癌又は肝硬変の診断薬及び診断法
JPH0772147A (ja) * 1993-07-02 1995-03-17 Noboru Kaneko 抗アネキシンｖ抗体並びに該抗体の製法及び利用
EP0651253A1 (de) * 1993-11-02 1995-05-03 Abbott Laboratories Immunoassay zum Nachweis menschlicher Autoantikörper
US5658877A (en) * 1995-05-18 1997-08-19 Wisconsin Alumni Research Foundation Method to treat endotoxin effects by administration of 33 kilodalton phospholipid binding protein
JP4065574B2 (ja) 1997-06-26 2008-03-26 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 細胞内蛋白質抗原および血清中の特異的細胞内蛋白質抗原に対する抗体の存在を同定するための方法
EP0965840A4 (de) * 1997-10-08 2001-10-31 Noboru Kaneko Methode zum analysieren von annexin v in urin und deren anwendung
AU762512B2 (en) * 1998-12-28 2003-06-26 Atossa Genetics, Inc. Devices, methods and systems for collecting material from a breast duct
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer

Also Published As

Publication number Publication date
EP1734368B1 (de) 2009-03-18
DE60028040D1 (de) 2006-06-22
US20060275845A1 (en) 2006-12-07
AU780772B2 (en) 2005-04-14
DK1734368T3 (da) 2009-06-02
DK1200832T3 (da) 2006-09-18
ES2259609T3 (es) 2006-10-16
WO2001011372A9 (en) 2002-04-11
US20070037227A1 (en) 2007-02-15
CA2380398C (en) 2017-01-31
JP4594575B2 (ja) 2010-12-08
ATE529751T1 (de) 2011-11-15
EP2051079A2 (de) 2009-04-22
DE60041839D1 (de) 2009-04-30
DE60028040T2 (de) 2006-11-23
EP1734368A2 (de) 2006-12-20
ES2320585T3 (es) 2009-05-25
CA2380398A1 (en) 2001-02-15
EP1734368A3 (de) 2007-03-07
EP2051079B1 (de) 2011-10-19
JP2003535309A (ja) 2003-11-25
EP1200832B1 (de) 2006-05-17
US6645465B2 (en) 2003-11-11
EP2051079A3 (de) 2009-06-10
ATE326699T1 (de) 2006-06-15
WO2001011372A1 (en) 2001-02-15
EP1200832A1 (de) 2002-05-02
US20020168696A1 (en) 2002-11-14
US7955602B2 (en) 2011-06-07
AU6526200A (en) 2001-03-05
US7759081B2 (en) 2010-07-20
US20040048320A1 (en) 2004-03-11
US20100330587A1 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
ATE426167T1 (de) Auto-antikírper gegen annexin-proteine als marker fur lungenkrebs
ATE246361T1 (de) Verfahren zur bestimmung von ige
Hill et al. Preserved proteins from extinct Bison latifrons identified by tandem mass spectrometry; hydroxylysine glycosides are a common feature of ancient collagen
DE69636075D1 (de) Verbindungen und verfahren zur diagnose von tuberkulose
PT991421E (pt) Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa
LU91756I2 (fr) Denosumab
TR200000113T2 (tr) Tüberkülozu teşhis etmek için bileşikler ve bunları kullanma yöntemleri.
ATE393912T1 (de) Microarrays und ihre verwendungen
ATE397660T1 (de) Zelloberflächen-antigen aus säugetieren und verwandte reagenzien
ATE516492T1 (de) Vorrichtung und verfahren zur multianalytbestimmung
ATE554106T1 (de) Antikörper für onkogene stämme von hpv und verfahren zu deren verwendung
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
DE69719057D1 (de) Verfahren zur signalverstärkung
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
WO2005019831B1 (en) Methods for reducing complexity of a sample using small epitope antibodies
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
WO2004109286A3 (en) Methods for detecting and treating cancer using podocalyxin and/or endoglycan
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
DE69811614D1 (de) Verfahren zur detektierung eines biologischen materials, eingangphase, detektionsphase und diese enthaltende reagenz
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
ATE421693T1 (de) Proteine in der diabetes-proteomanalyse
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
DE60311278D1 (de) Immunochromatographiesystem und verfahren zur gleichzeitigen identifikation von aga-und t-tg-antikörpern und verwendung dafür zur diagnose der zöliakiekrankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties